Inventor · disambiguated record
Zelanna Goldberg
Also filed as: GOLDBERG ZELANNA · GOLDBERG ZELANNA IRIS
1 granted patent·5 pending applications·6 citations·filing 2016–2024
30Inventor score
Top patents by PatentIndex Score
6 records- 0181US10869924B2PD-L1 antagonist combination treatmentsMERCK PATENT GMBH·Filed 2016·Granted Dec 22, 2020·6 cites·24 claims
- 0274US2024325446A1Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitorsIOVANCE BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0374US2025017971A1Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitorsIOVANCE BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0464US2024299539A1Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitorsIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0552US2021069326A1Pd-l1 antagonist combination treatmentsMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 0635US2019275049A1Combination of an EGFR T790M Inhibitor and a CDK Inhibitor for the Treatment of Non-Small Cell Lung CancerPFIZER·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zelanna Goldberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →